1. Bone scintigraphy in nasopharyngeal carcinoma.
- Author
-
Sundram FX, Chua ET, Goh AS, Toh HJ, Khor TH, and Chua EJ
- Subjects
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Bone Neoplasms diagnostic imaging, Child, Diphosphonates, Female, Humans, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Metastasis, Organotechnetium Compounds, Radionuclide Imaging, Technetium Tc 99m Medronate, Bone Neoplasms secondary, Nasopharyngeal Neoplasms pathology
- Abstract
One hundred and forty-three patients (Group 1) with histologically proven nasopharyngeal-carcinoma (NPC) had bone scintigraphy with 99Tcm methylenediphosphonate (MDP) or dihydroxypropanediphosphonate (DPD) within 2 months of the initial diagnosis. A further 162 patients (Group 2) had bone scans during the course of follow-up if there were symptoms of bone pain or evidence of metastases at other sites. Twenty-three per cent (33/143) of the newly diagnosed NPC patients (Group 1) had evidence of bone metastases. Of these 143 patients, 101 were T0-T2, 16 were T3 and 25 were T4. Thirty-six patients had no neck nodes (NO), 44 were N1, 25 N2 and 38 N3. Of the 162 patients in Group 2, 96 (59%) had a positive bone scan. The commonest sites for bony metastases from NPC were the spine, ribs, pelvis and lower limbs in order of frequency. There is a highly significant association with the nodal stage but no association with the UICC T staging which is not adequate in nasopharyngeal carcinoma. In our part of the world, bone metastases from NPC are a common cause of an abnormal bone scan.
- Published
- 1990
- Full Text
- View/download PDF